Drug Profile
BR 87023
Latest Information Update: 14 Aug 2007
Price :
$50
*
At a glance
- Originator Boryung
- Class Antivirals; Nucleosides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpesvirus infections
Most Recent Events
- 14 Aug 2007 Discontinued - Preclinical for Herpesvirus infections in South Korea (unspecified route)
- 14 Jul 1998 No development reported - Preclinical for Herpesvirus infections in South Korea (Unknown route)
- 09 Nov 1995 Preclinical development for Herpesvirus infections in South Korea (Unknown route)